Blood Pressure Dynamics in Heart Failure Management
Summary
Blood pressure regulation occupies a central role in both the onset and progression of heart failure. Hypertension is a major risk factor for the development of ventricular remodelling, diastolic dysfunction and eventual pump failure, whereas hypotension in established heart failure often signals advanced disease and portends poor prognosis. The interplay between arterial load, ventricular contractile reserve and neurohormonal activation defines haemodynamic status and guides therapeutic choice. Contemporary management aims to tailor blood pressure targets to ejection fraction subtypes, comorbidities and tolerance thresholds, balancing the prevention of end-organ damage against the risks of excessive blood pressure reduction. Optimising afterload, preserving organ perfusion and modulating maladaptive neurohormonal responses remain core objectives in both acute and chronic settings.
Research from Nature Portfolio
Recent investigations have elucidated the prognostic impact of initial blood pressure in acute heart failure admissions. In patients with reduced ejection fraction, systolic pressures below 120 mmHg and diastolic pressures below 80 mmHg at presentation independently doubled the risk of long-term mortality. Medication patterns differed by heart failure phenotype: those with reduced ejection fraction received guideline-directed renin-angiotensin and beta-blockade across the blood pressure spectrum, whereas in mildly reduced or preserved ejection fraction groups declining admission pressures were associated with lower uptake of these agents. These findings reinforce the need for early haemodynamic stratification and support tailored application of heart failure therapies according to initial blood pressure.
Blood Pressure Dynamics in Heart Failure Management publication trend
The graph below shows the total number of articles in blood pressure dynamics in heart failure management across all publications each year (not limited to Nature Index journals).
Technical terms
Ejection fraction: the proportion of left ventricular end-diastolic volume ejected during systole, expressed as a percentage.
HFrEF: heart failure with reduced ejection fraction, typically defined as ≤40%.
HFpEF: heart failure with preserved ejection fraction, usually defined as ≥50%.
HFmrEF: heart failure with mildly reduced ejection fraction, with values between 41% and 49%.
J-curve relationship: a non-linear association in which both low and high blood pressure extremes are linked to increased adverse outcomes.
Sodium–glucose cotransporter 2 (SGLT2) inhibitor: a class of glucose-lowering agents that reduce renal glucose reabsorption and exhibit cardiovascular and blood pressure-lowering effects.
Mineralocorticoid receptor antagonist: a drug class that blocks aldosterone action, reducing sodium retention, lowering blood pressure and improving cardiac remodelling.
References
- Hypertension and Heart Failure: From Pathophysiology to Treatment. International Journal of Molecular Sciences (2024).
- Effect of low blood pressure on prognosis of acute heart failure. Scientific Reports (2024).
- Blood pressure and heart failure: focused on treatment. Clinical Hypertension (2024).
- Systolic Blood Pressure and 1-Year Clinical Outcomes in Patients Hospitalized for Heart Failure. Frontiers in Cardiovascular Medicine (2022).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.